Virus cocktail takes on tough lung bugs in CF trial
Disease control
Not yet recruiting
This early-stage trial tests whether a mixture of natural viruses called AchromoPhage is safe for adults with cystic fibrosis who have long-term lung infections from Achromobacter bacteria. Twelve participants will receive the treatment by inhalation, IV, or both, and be monitore…
Phase: PHASE1 • Sponsor: Ghady Haidar • Aim: Disease control
Last updated May 06, 2026 16:14 UTC